Alrgn Bio Overview

  • Founded
  • 2014

  • Status
  • Out of Business

  • Employees
  • 2

  • Latest Deal Type
  • Out of Business

Alrgn Bio General Information


Operator of a food bioprocessing technology intended for hypoallergenic peanuts. The company's platform combines a patented food-grade enzymatic process with current food industry processing equipment to inactivate peanut allergens, enabling consumers with safer peanuts for a snack served to airplane passengers and peanut butter used in schools to a breakfast bar and a weightlifting powder.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Food Products
Other Industries
Other Consumer Non-Durables
Primary Office
  • 2901 E Gate City Boulevard
  • Suite 2400
  • Greensboro, NC 27401
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alrgn Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 29-Jun-2017 00000 Completed Out of Business
1. Seed Round 16-Dec-2016 00000 00000 00.000 Completed Startup
To view Alrgn Bio’s complete valuation and funding history, request access »

Alrgn Bio Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 0,000,000 00.00 00.00 00 00.00 00.000
To view Alrgn Bio’s complete cap table history, request access »

Alrgn Bio Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial